drugset / Trial / NCT00935389

Prospective Study of TW in the Treatment of LN Type V With Gross Proteinuria

NCT00935389

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to analyze the clinical effects and adverse reactions of tripterygium glycosides (TW) and CTX in LN-V patients with gross proteinuria.

Timeline

Start
2009-04
Primary completion
2011-04
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Tripterygium glycosides Traditional medicine (herbal / TCM) 20 mg
Subject Tripterygium glycosides Traditional medicine (herbal / TCM) 60 mg